Cancer Vaccines: State of the Art of the Computational Modeling Approaches

被引:11
作者
Pappalardo, Francesco [1 ]
Chiacchio, Ferdinando [2 ]
Motta, Santo [3 ]
机构
[1] Univ Catania, Dipartimento Sci Farm, I-95125 Catania, Italy
[2] Univ Catania, Dipartimento Ingn Elettr Elettron & Informat, I-95125 Catania, Italy
[3] Univ Catania, Dipartimento Matemat & Informat, I-95125 Catania, Italy
关键词
IMMUNOINFORMATICS; VACCINATION; IMMUNOTHERAPY; EFFICACY;
D O I
10.1155/2013/106407
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Cancer vaccines are a real application of the extensive knowledge of immunology to the field of oncology. Tumors are dynamic complex systems in which several entities, events, and conditions interact among them resulting in growth, invasion, and metastases. The immune system includes many cells and molecules that cooperatively act to protect the host organism from foreign agents. Interactions between the immune system and the tumor mass include a huge number of biological factors. Testing of some cancer vaccine features, such as the best conditions for vaccine administration or the identification of candidate antigenic stimuli, can be very difficult or even impossible only through experiments with biological models simply because a high number of variables need to be considered at the same time. This is where computational models, and, to this extent, immunoinformatics, can prove handy as they have shown to be able to reproduce enough biological complexity to be of use in suggesting new experiments. Indeed, computational models can be used in addition to biological models. We now experience that biologists and medical doctors are progressively convinced that modeling can be of great help in understanding experimental results and planning new experiments. This will boost this research in the future.
引用
收藏
页数:6
相关论文
共 29 条
[1]
Combining cellular automata and lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition [J].
Alemani, Davide ;
Pappalardo, Francesco ;
Pennisi, Marzio ;
Motta, Santo ;
Brusic, Vladimir .
JOURNAL OF IMMUNOLOGICAL METHODS, 2012, 376 (1-2) :55-68
[2]
Targeted therapies to improve tumor immunotherapy [J].
Begley, Jonathan ;
Ribas, Antoni .
CLINICAL CANCER RESEARCH, 2008, 14 (14) :4385-4391
[3]
Anti-idiotype antibody vaccine therapy for cancer [J].
Bhattacharya-Chatterjee, M ;
Chatterjee, SK ;
Foon, KA .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (08) :869-881
[4]
The immunoinformatics of cancer immunotherapy [J].
DeLuca, D. S. ;
Blasczyk, R. .
TISSUE ANTIGENS, 2007, 70 (04) :265-271
[5]
The three Es of cancer immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :329-360
[6]
Modeling flow cytometry data for cancer vaccine immune monitoring [J].
Frelinger, Jacob ;
Ottinger, Janet ;
Gouttefangeas, Cecile ;
Chan, Cliburn .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (09) :1435-1441
[7]
Opinion - The promise of cancer vaccines [J].
Gilboa, E .
NATURE REVIEWS CANCER, 2004, 4 (05) :401-411
[8]
Recent advances and current challenges in tumor immunology and immunotherapy [J].
Guinn, Barbara-ann ;
Kasahara, Noriyuki ;
Farzaneh, Farzin ;
Habib, Nagy A. ;
Norris, James S. ;
Deisseroth, Albert B. .
MOLECULAR THERAPY, 2007, 15 (06) :1065-1071
[9]
He YQ, 2010, J BIOMED BIOTECHNOL, P1, DOI [10.1155/2010/218590, 10.1155/2010/297505]
[10]
Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: A biotech's challenge [J].
Iurescia, Sandra ;
Fioretti, Daniela ;
Fazio, Vito Michele ;
Rinaldi, Monica .
BIOTECHNOLOGY ADVANCES, 2012, 30 (01) :372-383